1-44827908-G-A
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2
The NM_003738.5(PTCH2):c.1993C>T(p.Arg665Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00019 in 1,614,180 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R665H) has been classified as Likely benign.
Frequency
Consequence
NM_003738.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PTCH2 | NM_003738.5 | c.1993C>T | p.Arg665Cys | missense_variant | 14/22 | ENST00000372192.4 | NP_003729.3 | |
PTCH2 | NM_001166292.2 | c.1993C>T | p.Arg665Cys | missense_variant | 14/23 | NP_001159764.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PTCH2 | ENST00000372192.4 | c.1993C>T | p.Arg665Cys | missense_variant | 14/22 | 1 | NM_003738.5 | ENSP00000361266.3 | ||
PTCH2 | ENST00000447098.6 | c.1993C>T | p.Arg665Cys | missense_variant | 14/23 | 1 | ENSP00000389703.2 |
Frequencies
GnomAD3 genomes AF: 0.000519 AC: 79AN: 152220Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.000183 AC: 46AN: 251308Hom.: 0 AF XY: 0.000140 AC XY: 19AN XY: 135838
GnomAD4 exome AF: 0.000155 AC: 226AN: 1461842Hom.: 0 Cov.: 56 AF XY: 0.000144 AC XY: 105AN XY: 727220
GnomAD4 genome AF: 0.000525 AC: 80AN: 152338Hom.: 0 Cov.: 34 AF XY: 0.000591 AC XY: 44AN XY: 74474
ClinVar
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | Department of Pathology and Laboratory Medicine, Sinai Health System | - | The PTCH2 p.Arg665Cys variant was identified in one adolescent male with panhypopituitarism (El-Kholy_2019_PMID:31022718). The variant was identified in dbSNP (ID: rs138324984) and ClinVar (classified as likely benign by Invitae). The variant was not identified in the Cosmic but was identified in control databases in 62 of 282708 chromosomes at a frequency of 0.0002193 (Genome Aggregation Database March 6, 2019, v2.1.1). The variant was observed in the following populations: African in 28 of 24960 chromosomes (freq: 0.001122), Other in 3 of 7222 chromosomes (freq: 0.000415), Latino in 11 of 35434 chromosomes (freq: 0.00031), European (non-Finnish) in 19 of 129050 chromosomes (freq: 0.000147) and East Asian in 1 of 19950 chromosomes (freq: 0.00005), but was not observed in the Ashkenazi Jewish, European (Finnish), or South Asian populations. The p.Arg665 residue is not conserved in mammals and four out of five computational analyses (PolyPhen-2, SIFT, AlignGVGD, BLOSUM, MutationTaster) do not suggest a high likelihood of impact to the protein; however, this information is not predictive enough to rule out pathogenicity. The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) do not predict a difference in splicing. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time. This variant is classified as a variant of uncertain significance. - |
PTCH2-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Sep 13, 2022 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Gorlin syndrome Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 26, 2023 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at